Clinical trial
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
NCT00006357 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00006357 |
|---|---|
| Title | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma |
| Official title | Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer, Gastrointestinal Stromal Tumor, Ovarian Cancer, Sarcoma, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | imatinib mesylate |
| Enrollment | 91 |
| Start date | Aug 1, 2000 |
| Primary completion | Apr 1, 2001 |
| First posted | Apr 26, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, Denmark, France, Netherlands, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: